US Stock MarketDetailed Quotes

ACHL Achilles Therapeutics

Watchlist
  • 1.140
  • +0.159+16.18%
Close Dec 24 13:00 ET
46.84MMarket Cap-0.69P/E (TTM)

Achilles Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
6.92%20.42M
-1.62%17.8M
-22.93%14.3M
-3.99%75.26M
-14.54%19.51M
19.10%19.1M
-11.94%18.09M
-2.19%18.55M
22.10%78.38M
23.69%22.83M
Selling and administrative expenses
-8.28%4.02M
-3.57%4.16M
-11.23%4.16M
-19.46%17.01M
-8.49%3.62M
-19.37%4.38M
-25.16%4.32M
-21.33%4.69M
-3.87%21.12M
-40.51%3.96M
-General and administrative expense
-8.28%4.02M
-3.57%4.16M
-11.23%4.16M
-19.46%17.01M
-8.49%3.62M
-19.37%4.38M
-25.16%4.32M
-21.33%4.69M
-3.87%21.12M
-40.51%3.96M
Research and development costs
11.45%16.4M
-1.01%13.64M
-26.88%10.14M
1.72%58.25M
-15.81%15.89M
38.83%14.71M
-6.78%13.77M
6.56%13.87M
35.62%57.26M
59.87%18.88M
Operating profit
-6.92%-20.42M
1.62%-17.8M
22.93%-14.3M
3.99%-75.26M
14.54%-19.51M
-19.10%-19.1M
11.94%-18.09M
2.19%-18.55M
-22.10%-78.38M
-23.69%-22.83M
Net non-operating interest income expense
Other net income (expense)
-65.80%817K
17.74%1.43M
83.50%2M
-16.90%6.08M
217.61%1.39M
-33.62%2.39M
-62.95%1.21M
-33.03%1.09M
133.58%7.32M
-622.57%-1.18M
Other non- operating income (expenses)
-65.80%817K
17.74%1.43M
83.50%2M
-16.90%6.08M
217.61%1.39M
-33.62%2.39M
-62.95%1.21M
-33.03%1.09M
133.58%7.32M
-622.57%-1.18M
Income before tax
-17.32%-19.6M
3.01%-16.37M
29.58%-12.3M
2.66%-69.17M
24.53%-18.13M
-34.35%-16.71M
2.29%-16.88M
-0.70%-17.46M
-16.38%-71.07M
-31.70%-24.02M
Income tax
79.17%-5K
123.53%8K
-152.27%-23K
342.34%491K
1,131.71%505K
-158.54%-24K
-342.86%-34K
193.33%44K
200.00%111K
1,125.00%41K
Net income
-17.45%-19.6M
2.77%-16.38M
29.89%-12.27M
2.12%-69.67M
22.56%-18.63M
-33.72%-16.68M
2.56%-16.85M
-0.87%-17.51M
-16.49%-71.18M
-31.96%-24.06M
Net income continuous Operations
-17.45%-19.6M
2.77%-16.38M
29.89%-12.27M
2.12%-69.67M
22.56%-18.63M
-33.72%-16.68M
2.56%-16.85M
-0.87%-17.51M
-16.49%-71.18M
-31.96%-24.06M
Minority interest income
Net income attributable to the parent company
-17.45%-19.6M
2.77%-16.38M
29.89%-12.27M
2.12%-69.67M
22.56%-18.63M
-33.72%-16.68M
2.56%-16.85M
-0.87%-17.51M
-16.49%-71.18M
-31.96%-24.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-17.45%-19.6M
2.77%-16.38M
29.89%-12.27M
2.12%-69.67M
22.56%-18.63M
-33.72%-16.68M
2.56%-16.85M
-0.87%-17.51M
-16.49%-71.18M
-31.96%-24.06M
Basic earnings per share
-14.29%-0.48
2.38%-0.41
31.82%-0.3
4.40%-1.74
25.81%-0.46
-31.25%-0.42
4.55%-0.42
2.22%-0.44
14.55%-1.82
-40.91%-0.62
Diluted earnings per share
-14.29%-0.48
2.38%-0.41
31.82%-0.3
4.40%-1.74
25.81%-0.46
-31.25%-0.42
4.55%-0.42
2.22%-0.44
14.55%-1.82
-40.91%-0.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 6.92%20.42M-1.62%17.8M-22.93%14.3M-3.99%75.26M-14.54%19.51M19.10%19.1M-11.94%18.09M-2.19%18.55M22.10%78.38M23.69%22.83M
Selling and administrative expenses -8.28%4.02M-3.57%4.16M-11.23%4.16M-19.46%17.01M-8.49%3.62M-19.37%4.38M-25.16%4.32M-21.33%4.69M-3.87%21.12M-40.51%3.96M
-General and administrative expense -8.28%4.02M-3.57%4.16M-11.23%4.16M-19.46%17.01M-8.49%3.62M-19.37%4.38M-25.16%4.32M-21.33%4.69M-3.87%21.12M-40.51%3.96M
Research and development costs 11.45%16.4M-1.01%13.64M-26.88%10.14M1.72%58.25M-15.81%15.89M38.83%14.71M-6.78%13.77M6.56%13.87M35.62%57.26M59.87%18.88M
Operating profit -6.92%-20.42M1.62%-17.8M22.93%-14.3M3.99%-75.26M14.54%-19.51M-19.10%-19.1M11.94%-18.09M2.19%-18.55M-22.10%-78.38M-23.69%-22.83M
Net non-operating interest income expense
Other net income (expense) -65.80%817K17.74%1.43M83.50%2M-16.90%6.08M217.61%1.39M-33.62%2.39M-62.95%1.21M-33.03%1.09M133.58%7.32M-622.57%-1.18M
Other non- operating income (expenses) -65.80%817K17.74%1.43M83.50%2M-16.90%6.08M217.61%1.39M-33.62%2.39M-62.95%1.21M-33.03%1.09M133.58%7.32M-622.57%-1.18M
Income before tax -17.32%-19.6M3.01%-16.37M29.58%-12.3M2.66%-69.17M24.53%-18.13M-34.35%-16.71M2.29%-16.88M-0.70%-17.46M-16.38%-71.07M-31.70%-24.02M
Income tax 79.17%-5K123.53%8K-152.27%-23K342.34%491K1,131.71%505K-158.54%-24K-342.86%-34K193.33%44K200.00%111K1,125.00%41K
Net income -17.45%-19.6M2.77%-16.38M29.89%-12.27M2.12%-69.67M22.56%-18.63M-33.72%-16.68M2.56%-16.85M-0.87%-17.51M-16.49%-71.18M-31.96%-24.06M
Net income continuous Operations -17.45%-19.6M2.77%-16.38M29.89%-12.27M2.12%-69.67M22.56%-18.63M-33.72%-16.68M2.56%-16.85M-0.87%-17.51M-16.49%-71.18M-31.96%-24.06M
Minority interest income
Net income attributable to the parent company -17.45%-19.6M2.77%-16.38M29.89%-12.27M2.12%-69.67M22.56%-18.63M-33.72%-16.68M2.56%-16.85M-0.87%-17.51M-16.49%-71.18M-31.96%-24.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -17.45%-19.6M2.77%-16.38M29.89%-12.27M2.12%-69.67M22.56%-18.63M-33.72%-16.68M2.56%-16.85M-0.87%-17.51M-16.49%-71.18M-31.96%-24.06M
Basic earnings per share -14.29%-0.482.38%-0.4131.82%-0.34.40%-1.7425.81%-0.46-31.25%-0.424.55%-0.422.22%-0.4414.55%-1.82-40.91%-0.62
Diluted earnings per share -14.29%-0.482.38%-0.4131.82%-0.34.40%-1.7425.81%-0.46-31.25%-0.424.55%-0.422.22%-0.4414.55%-1.82-40.91%-0.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.53%